Cancer

Main Content

GRAVITAS-301

Study title

Randomized double blind placebo controlled phase 3 study of Itacitinib or placebo in combination with corticosteroids for the treatment of first line acute graft versus host disease

  • Principal Investigator: Dr. Carolyn Bigelow

Purpose

This study is evaluating the efficacy of an experimental drug in combination with corticosteroids in bone marrow transplant patients with acute graft versus host disease.

Who can participate

Those eligible to participate in this study include:

  • Adults 18 and over who have undergone a bone marrow transplant with acute graft vs. host disease.

For more information

  • Susan Johnson
    University of Mississippi Medical Center
    2500 N. State St.
    Jackson, MS 39216
    (601) 815-3074
  • IRB Number: 2017-0158